Ductal carcinoma in situ (DCIS) is a non-invasive malignant neoplasm arising from the epithelial cells of breast ducts that has not penetrated the basement membrane. It accounts for 20-25% of all breast cancers and its incidence has markedly increased with widespread screening mammography. DCIS most commonly presents as calcifications on mammography — particularly pleomorphic (fine irregular) and fine linear/branching calcifications suggest high-grade DCIS. Calcifications with segmental or linear distribution reflect spread along the ductal system. Mass formation is uncommon but may be seen especially in high-grade DCIS with comedo necrosis. On MRI, non-mass enhancement (segmental/linear/ductal) is the most sensitive finding for DCIS — MRI can detect 25-40% of mammographically occult DCIS. Untreated DCIS carries a 25-50% risk of progression to invasive carcinoma. In BI-RADS classification, suspicious calcifications are categorized as BI-RADS 4-5 and require stereotactic biopsy.
Age Range
40-70
Peak Age
55
Gender
Female predominant
Prevalence
Common
DCIS is a neoplastic proliferation of epithelial cells in the terminal ductal lobular unit of the breast. Neoplastic cells fill the ductal lumen but do not breach the basement membrane and myoepithelial cell layer — this feature is the fundamental histopathological criterion distinguishing DCIS from invasive carcinoma. In high-grade DCIS, central comedo necrosis develops — necrotic cell debris undergoes dystrophic calcification and appears on mammography as characteristic fine pleomorphic or fine linear/branching calcifications. These calcifications reflect the shape of the ductal lumen — linear calcifications represent extension along ducts, branching calcifications show ductal bifurcations. Segmental distribution reflects DCIS originating from a single ductal segment and spreading into branch ducts — this pattern is typically seen on mammography as a triangular configuration with the apex pointing toward the nipple. In low-grade DCIS, psammomatous or amorphous calcifications may be seen — these are less specific. On MRI, DCIS shows enhancement due to tumor neoangiogenesis; however, unlike invasive tumors, it typically produces non-mass enhancement pattern without mass formation — reflecting neoplastic cell spread along ducts and microvessel formation.
Fine linear and branching calcifications reflecting the shape of the ductal lumen — formed by dystrophic calcification of necrotic tumor debris. Most specific mammographic finding of high-grade DCIS, classified as BI-RADS 5. The term 'casting' refers to calcifications assuming the 'mold' shape of the duct.
Irregularly shaped and sized granular or heterogeneous calcifications. Typically show segmental or linear distribution. Strongly correlated with high-grade DCIS. Calcifications are less than 0.5 mm and have varying shapes.
Report Sentence
Fine pleomorphic calcifications with segmental distribution are observed in the upper outer quadrant of the left breast, suggesting DCIS (ductal carcinoma in situ); stereotactic biopsy is recommended (BI-RADS 4B).
Fine (<0.5 mm), linear and branching calcifications. Mimic the shape of the ductal lumen — also known as 'casting type' calcifications. This is the calcification type with the highest predictive value for DCIS. Branching reflects ductal bifurcations.
Report Sentence
Fine linear and branching calcifications with linear distribution are observed in the upper outer quadrant of the breast, consistent with high-grade DCIS; stereotactic biopsy is recommended (BI-RADS 5).
Triangular or wedge-shaped distribution of calcifications corresponding to a single ductal segment. Apex points toward the nipple, base toward the chest wall. This distribution pattern is the mammographic correlate of DCIS spreading along ducts and reflects the true extent of the lesion.
Report Sentence
Calcifications show segmental distribution corresponding to a single ductal segment, a pattern consistent with DCIS (ductal carcinoma in situ).
Enhancement without mass formation in segmental, linear, or ductal pattern on contrast-enhanced breast MRI (non-mass enhancement — NME). Internal enhancement pattern is clumped or heterogeneous. Kinetic curve typically shows Type I (persistent) or Type II (plateau) — Type III (washout) is less common.
Report Sentence
Non-mass enhancement with clumped pattern showing segmental distribution is observed in the left breast on contrast-enhanced MRI, suggesting DCIS; MRI-guided biopsy or second-look ultrasound is recommended.
High signal on DWI with low signal on ADC map (diffusion restriction). Reflects restricted water molecule movement due to increased cellularity in high-grade DCIS. ADC value typically <1.3 x 10⁻³ mm²/s. Diffusion restriction is less pronounced in low-grade DCIS.
Report Sentence
Diffusion restriction is observed in the region corresponding to the calcification area, consistent with high-grade DCIS.
On ultrasound, DCIS typically shows no definitive findings. However, in high-grade or extensive DCIS, ductal dilatation, intraductal hypoechoic solid lesion, microcalcifications (bright echogenic foci), or architectural distortion may be seen. US is complementary to mammography and is not the primary screening modality.
Report Sentence
An intraductal hypoechoic lesion is observed on ultrasound in the region corresponding to the mammographic calcification area, which may be consistent with DCIS; stereotactic biopsy is recommended for correlation.
Small, indistinct, dust-like calcifications. Specificity is lower compared to pleomorphic and linear calcifications. May be associated with low/intermediate grade DCIS. Suspicion increases when grouped or segmental distribution is present. Requires detailed morphological assessment with magnification mammography.
Report Sentence
Grouped amorphous calcifications are observed; low-grade DCIS cannot be excluded; magnification mammography and clinical correlation are recommended (BI-RADS 4A).
Criteria
Large, pleomorphic cells with high mitotic activity and central comedo necrosis. Nuclear grade 3. Most aggressive type with highest risk of progression to invasive carcinoma.
Distinct Features
Fine linear/branching or fine pleomorphic calcifications are typical on mammography. Segmental or linear distribution. Prominent enhancement and Type II-III kinetic curve on MRI. Calcifications may be denser and spread over a wider area. Comedo necrosis may appear as low-density center on CT.
Criteria
Medium-sized cells, moderate mitotic activity, focal necrosis may or may not be present. Nuclear grade 2. Shows biological behavior between low and high grade.
Distinct Features
Calcification morphology is variable — may be amorphous or fine pleomorphic. MRI findings may be less prominent than high-grade. Grouped or segmental distribution on mammography.
Criteria
Small, uniform cells, low mitotic activity, necrosis typically absent. Nuclear grade 1. Slowest progressing type — annual risk of progression to invasive carcinoma ~1%.
Distinct Features
Amorphous or psammomatous calcifications on mammography — may be clinically difficult to distinguish from benign calcifications. Enhancement on MRI may be minimal or absent. Diffusion restriction on DWI may not be expected due to low cellularity.
Criteria
DCIS in the retroareolar region with Paget cells (intraepidermal malignant cells) in the nipple skin. Clinical findings include eczematous changes, erosion, or ulceration of the nipple.
Distinct Features
Abnormal enhancement of the nipple and retroareolar region on MRI. Retroareolar calcifications or nipple retraction on mammography. Retroareolar hypoechoic lesion on US. Thickening and enhancement of nipple skin on MRI suggests Paget's disease.
Distinguishing Feature
Invasive ductal carcinoma forms a mass (spiculated or irregularly marginated) — mass is typically absent in DCIS and diagnosis relies on calcifications. Architectural distortion is prominent in IDC.
Distinguishing Feature
LCIS is typically invisible on mammography — does not produce calcifications or mass. DCIS presents with calcifications. LCIS is a bilateral risk marker while DCIS is a local premalignant lesion.
Distinguishing Feature
Fibroadenoma shows coarse ('popcorn' type) calcifications — these are large, round, and homogeneous. DCIS calcifications are fine, pleomorphic, and linear/branching, morphologically distinctly different. Fibroadenoma forms a mass, DCIS typically does not.
Distinguishing Feature
Fat necrosis shows rim calcification (eggshell type, thin peripheral) or negative density center due to oil cyst — calcifications are coarse and peripheral. DCIS calcifications are fine, intraductal, and segmentally distributed. Fat necrosis is associated with trauma/surgical history.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralDCIS is a premalignant lesion with a 25-50% risk of progression to invasive carcinoma if untreated. Stereotactic vacuum-assisted biopsy is the gold standard for suspicious calcifications. If biopsy confirms DCIS, wide local excision (breast-conserving surgery + radiotherapy) or mastectomy is performed. Sentinel lymph node biopsy is recommended in high-grade or extensive DCIS — upgrade rate (DCIS on biopsy, invasive carcinoma at surgery) is 15-25%. MRI is recommended for extent assessment in surgical planning. Adjuvant tamoxifen or aromatase inhibitor reduces recurrence risk in hormone receptor-positive DCIS.
DCIS is a pre-invasive lesion with excellent prognosis when treated early. Treatment options include lumpectomy + radiotherapy or mastectomy. High-grade DCIS carries higher risk of invasive carcinoma. Sentinel lymph node biopsy should be considered in large DCIS lesions.